Intrinsic Value of S&P & Nasdaq Contact Us

Alcon Inc. ALC NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • CH • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
$153.96
+92.6%
Analyst Price Target
$91.02
+13.9%

Alcon Inc. (ALC) generated $2.27B in operating cash flow for fiscal year 2025. After capital expenditures of $543M, free cash flow was $1.73B.

Free cash flow margin was 16.6% of revenue. Cash conversion ratio was 2.32x, indicating earnings are backed by cash.

The company returned $166M in dividends and $723M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (80/100, Pass) — $1.73B (16.6% FCF margin) supports a durable competitive advantage
  • INCOME (45/100) — Cash conversion ratio was 2.32x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
72/100
SG Score
View full scorecard →
~
VALUE
44/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
80/100
Proven by this page
GROWTH
83/100
→ Income
~
INCOME
45/100
→ Income
Alcon Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $2.25B$2.27B$2.08B$1.39B$1.22B
Capital Expenditure $-431.08M$-543M$-670M$-851M$-745M
Free Cash Flow $1.81B$1.73B$1.41B$537M$472M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message